Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

autologous rapamycin-resistant Th1/Tc1 cells RAPA-201

A preparation of autologous rapamycin-resistant Th1/Tc1 cells, with potential immunomodulating activity. Upon administration, autologous rapamycin-resistant Th1/Tc1 cells RAPA-201 may recognize and kill tumor cells. Ex-vivo induction of rapamycin-resistance may increase the persistence of T-cells after adoptive transfer.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Code name:	RAPA 201 RAPA-201 RAPA201

autologous rapamycin-resistant Th1/Tc1 cells RAPA-201

Search NCI's Drug Dictionary